Effect of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on the Severity of Symptoms in Individuals With Narcolepsy Type 1: Results From Two Phase 3 Studies

Sleep Medicine 2026

View at publisher
Authors: Lucie Barateau, Isabelle Arnulf, Yves A Dauvilliers, C. Liguori, Fabio Pizza, Oliver Sum‐Ping, Ellie Stukalin, Tomas P Olsson, P. von Rosenstiel
DOI: 10.1016/j.sleep.2025.107508
Cited by: 0

Fields of Study & Subjects

Sleep and Wakefulness Research Sleep and related disorders Obstructive Sleep Apnea Research

Publication details

Journal / source
Sleep Medicine
Volume
138
Pages
107508–107508
Publication date
29 January 2026
Language
EN